(Adnkronos) - “Recupera e respira’ è un progetto che si basa sul corretto smaltimento dei device respiratori esauriti, ovvero gli inalatori che vengono utilizzati dai pazienti con patologie respiratorie. L’iniziativa evita che ci siano emissioni di gas a effetto serra, rappresentate dal residuo di propellente nei device spray.” Lo ha detto Raffaello Innocenti, ceo e managing director di Chiesi Italia nel presentare i risultati del progetto “Recupera e Respira”, ideato e promosso da Chiesi Italia e Federfarma, con il supporto della Regione Friuli Venezia Giulia. L’iniziativa ha permesso di raccogliere oltre 73 mila gli inalatori coinvolgendo 360 farmacie della regione.
Category
🗞
NewsTranscript
00:00Recupera e Respira is the title of the project that is presented today, what are its winning elements?
00:11The winning elements is that it is perfectly consistent with the objective of Chiesi Gruppo,
00:17also of Chiesi Italia, to reach net zero emissions by 2035,
00:21therefore 15 years earlier than the Paris agreements.
00:25This project is based on the correct disposal of all respiratory devices,
00:29once discharged, which are used by patients with respiratory pathologies.
00:34This avoids the emission of greenhouse gases,
00:38which are represented by propellant residues in the spray devices.
00:43The correct disposal takes place through a thermovalorizer at a temperature of 1100°C,
00:49which also produces electric energy that is emitted in the region, in this case from Venice Giulia.
00:55Chiesi Gruppo and Chiesi Italia are a benefit society,
00:59so they put in the center a different way of doing business that is based on the shared value.
01:05So in the center there are not only the patients, but there is also the society and the environment.